BARER SOL J

Average Profitability
<0.0001%
Insider Buys Quantity
21
Insider Buys Sum
$12.42M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of BARER SOL J

The largest purchase of all time was on 2013-04-16 and amounted to 1500000 shares of InspireMD, Inc. for $3M.

Biography of BARER SOL J

No biography is available at this moment.

2019-06-04PurchaseTeva Pharmaceutical Industries Limited
TEVA
director
209,000
0.0193%
$9.60$2.01M-2.94%
2019-06-03PurchaseTeva Pharmaceutical Industries Limited
TEVA
director
222,000
0.0205%
$8.98$1.99M+3.93%
2016-03-21PurchaseInspireMD, Inc.
NSPR
director
847,458
8.8183%
$0.59$500,000-80.33%
2015-10-06PurchasePDS Biotechnology Corporation
PDSB
director
90,000
0.2016%
$11.00$990,000-45.67%
2015-03-09PurchaseInspireMD, Inc.
NSPR
director
5M
11.0072%
$0.47$2.38M-39.33%
2014-11-07PurchaseInspireMD, Inc.
NSPR
director
192,308
0.512%
$1.30$250,000-76.61%
2014-05-13PurchaseInspireMD, Inc.
NSPR
director
90,400
0.2749%
$2.44$221,028-88.16%
2014-05-12PurchaseInspireMD, Inc.
NSPR
director
9,600
0.0296%
$2.42$23,203-87.87%
2013-05-31PurchaseInspireMD, Inc.
NSPR
director
40,000
0.1198%
$2.26$90,400
2013-05-30PurchaseInspireMD, Inc.
NSPR
director
40,000
0.1185%
$2.07$82,800
2013-05-29PurchaseInspireMD, Inc.
NSPR
director
40,000
0.1169%
$2.09$83,600
2013-05-28PurchaseInspireMD, Inc.
NSPR
director
40,000
0.1228%
$2.15$86,000
2013-05-24PurchaseInspireMD, Inc.
NSPR
director
40,000
0.1208%
$2.10$84,000
2013-04-25PurchaseInspireMD, Inc.
NSPR
director
100,000
0.2973%
$2.00$200,000
2013-04-16PurchaseInspireMD, Inc.
NSPR
director
1.5M
4.8375%
$2.00$3M
2013-03-15PurchaseAmicus Therapeutics, Inc.
FOLD
director
25,000
0.0516%
$3.40$85,000-24.1%
2012-11-21PurchaseInspireMD, Inc.
NSPR
director
69,960
0.1384%
$1.33$93,033
2012-11-20PurchaseInspireMD, Inc.
NSPR
director
30,040
0.0549%
$1.29$38,899
2012-11-19PurchaseInspireMD, Inc.
NSPR
director
28,882
0.0548%
$1.38$39,984
2012-11-16PurchaseInspireMD, Inc.
NSPR
director
71,118
0.1153%
$1.27$90,206
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.